Their work emphasized the complex interplay between MLL fusion proteins and cellular origin in determining AML characteristics, where ZEB1 and ZEB2 emerge as potential mediators in the MLL-driven leukemic processes. This evidence concerns the gene ZEB2 and acute myeloid leukemia.